Close

Ratings by Goldman Sachs (Corinne Jenkins)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/14/2024 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
1/25/2024 Rhythm Pharmaceuticals RYTM Maintain Buy
(N/A)
 
 
  Details
1/25/2024 Ideaya Biosciences IDYA Maintain Buy
(N/A)
 
 
  Details
1/25/2024 Fulcrum Therapeutics FULC Maintain Neutral
(N/A)
 
 
  Details
1/24/2024 Altimmune ALT New Coverage Neutral
(N/A)
10.04
(9.20)
-8.37% Details
1/18/2024 Intra-Cellular Therapies ITCI Maintain Neutral
(N/A)
 
 
  Details
1/18/2024 Halozyme Therapeutics HALO Maintain Neutral
(N/A)
 
 
  Details
1/9/2024 Harmony Biosciences Holdings Inc. HRMY Maintain Sell
(N/A)
 
 
  Details
12/6/2023 Rhythm Pharmaceuticals RYTM Maintain Buy
(N/A)
 
 
  Details
11/28/2023 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
11/15/2023 Ambrx Biopharma AMAM Maintain Neutral
(N/A)
 
 
  Details
11/10/2023 Amylyx Pharmaceuticals inc. AMLX Maintain Buy
(N/A)
 
 
  Details
10/16/2023 Halozyme Therapeutics HALO Maintain Neutral
(N/A)
 
 
  Details
10/16/2023 Harmony Biosciences Holdings Inc. HRMY Maintain Sell
(N/A)
 
 
  Details
9/27/2023 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
9/25/2023 Fulcrum Therapeutics FULC New Coverage Neutral
(N/A)
4.09
(9.60)
134.72% Details
9/25/2023 Alector Inc. ALEC New Coverage Sell
(N/A)
6.03
(6.41)
6.3% Details
9/25/2023 Harmony Biosciences Holdings Inc. HRMY Downgrade Sell
(Neutral)
35.72
(32.50)
-9.01% Details
9/13/2023 Ambrx Biopharma AMAM Maintain Neutral
(N/A)
 
 
  Details
9/12/2023 Geron Corporation GERN Upgrade Buy
(Neutral)
2.45
(1.96)
-20% Details
9/11/2023 Ideaya Biosciences IDYA Maintain Buy
(N/A)
 
 
  Details
8/15/2023 BioXcel Therapeutics BTAI Maintain Neutral
(N/A)
 
 
  Details
8/2/2023 TG Therapeutics TGTX Upgrade Neutral
(Sell)
10.49
(13.32)
26.98% Details
7/24/2023 Halozyme Therapeutics HALO Downgrade Neutral
(Buy)
42.57
(40.56)
-4.72% Details
7/24/2023 Amylyx Pharmaceuticals inc. AMLX Upgrade Buy
(Neutral)
22.41
(17.65)
-21.24% Details
7/21/2023 TG Therapeutics TGTX Maintain Sell
(N/A)
 
 
  Details
7/19/2023 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
7/3/2023 BioXcel Therapeutics BTAI Maintain Neutral
(N/A)
 
 
  Details
6/7/2023 Harmony Biosciences Holdings Inc. HRMY Maintain Neutral
(N/A)
 
 
  Details
5/26/2023 BioXcel Therapeutics BTAI Maintain Neutral
(N/A)
 
 
  Details
5/24/2023 Ideaya Biosciences IDYA New Coverage Buy
(N/A)
22.25
(45.88)
106.2% Details
5/12/2023 Geron Corporation GERN Maintain Neutral
(N/A)
 
 
  Details
5/5/2023 Terns Pharmaceuticals TERN Maintain Buy
(N/A)
 
 
  Details
5/1/2023 TG Therapeutics TGTX Maintain Sell
(N/A)
 
 
  Details
3/28/2023 Intra-Cellular Therapies ITCI Maintain Neutral
(N/A)
 
 
  Details
3/28/2023 Geron Corporation GERN New Coverage Neutral
(N/A)
2.33
(1.96)
-15.88% Details
3/22/2023 Altimmune ALT Downgrade Neutral
(Buy)
10.92
(9.20)
-15.75% Details
3/15/2023 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
3/14/2023 Rapt Therapeutics RAPT Maintain Buy
(N/A)
 
 
  Details
3/7/2023 Aclaris Therapeutis ACRS Maintain Buy
(N/A)
 
 
  Details
3/2/2023 Rhythm Pharmaceuticals RYTM Maintain Buy
(N/A)
 
 
  Details
2/27/2023 Ambrx Biopharma AMAM Maintain Neutral
(N/A)
 
 
  Details
2/21/2023 Harmony Biosciences Holdings Inc. HRMY Maintain Neutral
(N/A)
 
 
  Details
1/26/2023 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
1/26/2023 Rhythm Pharmaceuticals RYTM Maintain Buy
(N/A)
 
 
  Details
1/26/2023 BioXcel Therapeutics BTAI Maintain Neutral
(N/A)
 
 
  Details
1/19/2023 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
1/5/2023 Roivant Sciences ROIV Maintain Buy
(N/A)
 
 
  Details
12/29/2022 TG Therapeutics TGTX Maintain Sell
(N/A)
 
 
  Details
12/20/2022 Altimmune ALT Maintain Buy
(N/A)
 
 
  Details
12/19/2022 Terns Pharmaceuticals TERN Maintain Buy
(N/A)
 
 
  Details
12/1/2022 BioXcel Therapeutics BTAI Upgrade Neutral
(Sell)
15.18
(3.07)
-79.78% Details
12/1/2022 Altimmune ALT New Coverage Buy
(N/A)
9.46
(9.20)
-2.75% Details
12/1/2022 Aclaris Therapeutis ACRS New Coverage Buy
(N/A)
15.79
(1.19)
-92.46% Details
12/1/2022 Rapt Therapeutics RAPT New Coverage Buy
(N/A)
17.07
(8.72)
-48.92% Details
11/9/2022 Rhythm Pharmaceuticals RYTM Maintain Buy
(N/A)
 
 
  Details
11/1/2022 Harmony Biosciences Holdings Inc. HRMY Maintain Sell
(N/A)
 
 
  Details
9/27/2022 Terns Pharmaceuticals TERN Maintain Buy
(N/A)
 
 
  Details
9/8/2022 Rhythm Pharmaceuticals RYTM Maintain Buy
(N/A)
 
 
  Details
8/22/2022 Gritstone Oncology GRTS Downgrade Sell
(Neutral)
4.49
(2.22)
-50.56% Details
8/22/2022 Intra-Cellular Therapies ITCI Downgrade Neutral
(Buy)
50.74
(70.16)
38.27% Details
8/8/2022 Rhythm Pharmaceuticals RYTM Upgrade Buy
(Neutral)
18.59
(45.16)
142.93% Details
7/12/2022 Harmony Biosciences Holdings Inc. HRMY Downgrade Neutral
(Buy)
54.70
(32.50)
-40.59% Details
7/12/2022 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
6/23/2022 Athira Pharma ATHA Maintain Neutral
(N/A)
 
 
  Details
5/24/2022 Rovi Corp. ROVI Maintain Buy
(N/A)
 
 
  Details
5/24/2022 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
5/9/2022 BioXcel Therapeutics BTAI Maintain Sell
(N/A)
 
 
  Details
5/4/2022 Rhythm Pharmaceuticals RYTM Maintain Neutral
(N/A)
 
 
  Details
3/1/2022 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
2/28/2022 Ambrx Biopharma AMAM New Coverage Neutral
(N/A)
4.26
(27.94)
555.87% Details
2/25/2022 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
2/24/2022 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
2/16/2022 Intra-Cellular Therapies ITCI New Coverage Buy
(N/A)
53.00
(70.16)
32.38% Details
12/15/2021 Gritstone Oncology GRTS New Coverage Neutral
(N/A)
11.88
(2.22)
-81.31% Details
12/15/2021 Athira Pharma ATHA New Coverage Neutral
(N/A)
13.17
(3.93)
-70.16% Details
12/15/2021 Roivant Sciences ROIV New Coverage Buy
(N/A)
8.26
(11.60)
40.44% Details
12/10/2021 Radius Health RDUS Downgrade Neutral
(Buy)
8.01
(23.97)
199.25% Details
12/1/2021 BioXcel Therapeutics BTAI Maintain Sell
(N/A)
 
 
  Details
11/30/2021 TG Therapeutics TGTX Maintain Sell
(N/A)
 
 
  Details
11/15/2021 BioXcel Therapeutics BTAI Downgrade Sell
(Buy)
33.05
(3.07)
-90.71% Details
11/4/2021 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
10/20/2021 Radius Health RDUS Maintain Buy
(N/A)
 
 
  Details
9/14/2021 Terns Pharmaceuticals TERN New Coverage Buy
(N/A)
11.12
(8.13)
-26.89% Details
9/14/2021 Rhythm Pharmaceuticals RYTM New Coverage Neutral
(N/A)
12.98
(45.16)
247.92% Details
9/14/2021 Rain Therapeutics RAIN New Coverage Neutral
(N/A)
16.69
(1.21)
-92.75% Details
8/5/2021 Radius Health RDUS Maintain Buy
(N/A)
 
 
  Details
7/20/2021 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
6/22/2021 Acceleron Pharma XLRN Maintain Neutral
(N/A)
 
 
  Details
3/22/2021 Spring Works Therapeutics SWTX New Coverage Buy
(N/A)
68.20
(49.12)
-27.98% Details
3/22/2021 Radius Health RDUS New Coverage Buy
(N/A)
21.99
(8.01)
-63.57% Details
3/22/2021 Acceleron Pharma XLRN New Coverage Neutral
(N/A)
133.58
(178.75)
33.81% Details